. . . . . . . . . . . . . . . "a(CHEBI:fulvestrant) -| tscript(p(HGNC:ESR1))" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "1.4" . "Pure anti-oestrogens, such as ICI 164, 384 and faslodex, prevent activation of AF1 and AF2 (REF. 62), as well as reducing the half-life of the ER 63,64, and are anti-oestrogenic in all tissues." . . "Selventa" . . . . "2014-07-03T14:30:10.997+02:00"^^ . . .